How Much Did Olipop Raise? Funding & Key Investors

Olipop has successfully raised significant funding through multiple rounds, including a Series C round, achieving a valuation that places it among the unicorns. The company offers a range of prebiotic sodas designed to support digestive health while catering to diverse taste preferences.

Keep reading to explore the intricacies of Olipop's fundraising journey and the investors backing this innovative beverage brand.

What Is Olipop?

Olipop, founded in 2017 by Ben Goodwin and David Lester, is based in Oakland, California. The company specializes in creating prebiotic sodas that support digestive health while offering a variety of flavors to suit different taste preferences.

With a team of 51-100 employees, Olipop has positioned itself as a clinically backed consumer beverage company. Their products are designed to benefit the microbiome, digestive function, and metabolic health.

For more detailed information about Olipop, you can visit their Crunchbase profile or their official website.

How Much Funding Has Olipop Raised?

1. Pre-Seed Round
   • Amount Raised: Not publicly disclosed
   • Date: April 2018
   • Lead Investors: Finn Capital Partners
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To develop the initial product and launch the brand.
2. Seed Round
   • Amount Raised: $2.5M
   • Date: January 2019
   • Lead Investors: Peter Rahal
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To scale production and expand the team.
3. Series A
   • Amount Raised: $10M
   • Date: January 2020
   • Lead Investors: Finn Capital Partners
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To enhance marketing efforts and increase distribution.
4. Debt Financing
   • Amount Raised: $1M
   • Date: August 2020
   • Lead Investors: Dwight Funding
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To support operational costs and manage cash flow.
5. Series B
   • Amount Raised: $30M
   • Date: February 2022
   • Lead Investors: Monogram Capital Partners
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To accelerate growth and expand product offerings.
6. Series C
   • Amount Raised: $50M
   • Date: February 2025
   • Lead Investors: J.P. Morgan Growth Equity Partners
   • Valuation at Round: $1.85 billion
   • Motivation Behind the Round: To expand the product lineup, marketing, and distribution.

Total Amount Raised: $93.5M. Current Valuation: $1.85 billion.

Key Investors

• J.P. Morgan Growth Equity Partners
  • Details: J.P. Morgan Growth Equity Partners is a division of J.P. Morgan that focuses on growth equity investments. They provide capital to companies with high growth potential.
  • Investment Focus Areas: Technology, healthcare, consumer goods.
  • Notable Investments: Not publicly disclosed.
• Monogram Capital Partners
  • Details: Monogram Capital Partners is a private equity firm that invests in consumer and retail companies. They aim to partner with founders and management teams to drive growth.
  • Investment Focus Areas: Food and beverage, health and wellness, beauty and personal care.
  • Notable Investments: Not publicly disclosed.
• Finn Capital Partners
  • Details: Finn Capital Partners is an investment firm that provides early-stage funding to innovative companies. They focus on supporting startups with strong growth potential.
  • Investment Focus Areas: Technology, consumer products, healthcare.
  • Notable Investments: Not publicly disclosed.
• Peter Rahal
  • Details: Peter Rahal is an entrepreneur and investor, best known for co-founding RXBAR, a protein bar company. He has since become an active investor in the food and beverage industry.
  • Investment Focus Areas: Food and beverage, health and wellness, consumer goods.
  • Notable Investments: Not publicly disclosed.
• Dwight Funding
  • Details: Dwight Funding is a financial services firm that provides debt financing to growing companies. They specialize in offering flexible capital solutions to support business growth.
  • Investment Focus Areas: Consumer products, technology, healthcare.
  • Notable Investments: Not publicly disclosed.

What's Next for Olipop?

Olipop's future looks promising as it continues to capitalize on the growing demand for prebiotic and functional beverages. With annual sales surpassing $400 million, the company is well-positioned to expand its product lineup and increase its market share in the nonalcoholic beverage sector. The recent $50 million Series C funding round, led by J.P. Morgan Growth Equity Partners, underscores the significant growth potential and investor confidence in Olipop's innovative approach.

Future fundraising opportunities are likely, given the brand's impressive trajectory and profitability achieved in early 2024. Additional rounds of venture capital or private equity investments could further fuel Olipop's expansion and attract more high-profile investors. However, the company will need to navigate challenges such as maintaining profitability while scaling operations and competing with other established brands. Ensuring consistent product quality and innovation will be crucial to meeting consumer demands and sustaining growth.

Use Clay to Get Funding Data

Sales professionals, take your strategy to the next level by leveraging Clay's platform to access comprehensive fundraising data on companies like Olipop and gather other critical business insights.

Sign up for free on Clay and start making data-driven decisions today.